Peeyush Shivhare
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Peeyush Shivhare has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Naqoosh Haidry
Department of Oral and Maxillofacial Surgery, All India Institute of Medical Sciences (AIIMS), Patna, India
7 shared publications - Abhishek Gupta
Department of Oral Medicine and Radiology, Chitwan Medical College, Bharatpur, Nepal
5 shared publications Lata Shankarnarayan
Professor, Head of the Department, Rungta College of Dental Sciences and Research, Bhilai, Chhattisgarh, India
4 shared publications- Ejaz Ahmad Mokhtar
Department of Dentistry, All India Institute of Medical Sciences, Patna, India
3 shared publications - Neha Sah
Department of Dentistry, Maa Vindhyavasini Autonomous State Medical College, Mirzapur, Uttar Pradesh, India
3 shared publications - Shalini Subramanyam
Private Dental Clinic, Bangalore 560038, India
3 shared publications
Latest Publications
- Open Access
- 31 May 2025
- Published by Biomedical Informatics in Bioinformation
- Vol. 21 (05) , 1087-1092
Efficacy of colchicine in oral submucous fibrosis: A systematic review and meta-analysis
One of the potentially malignant disorders of the oral mucosa in Asian nations is known as oral submucous fibrosis (OSMF). The drug, surgical and combination therapies are some of the several OSMF treatment options. The importance of colchicine in the treatment of oral submucous fibrosis is still unclear. Therefore, it is of interest to review the efficacy of colchicine in oral submucous fibrosis in terms of improving symptoms such as burning sensation and mouth opening. Known data shows colchicine is in alleviating these symptoms in OSMF patients.
- 31 May 2025
- Published by Biomedical Informatics in Bioinformation
- Vol. 21 (05) , 1087-1092
Open AccessEfficacy of colchicine in oral submucous fibrosis: A systematic review and meta-analysis
One of the potentially malignant disorders of the oral mucosa in Asian nations is known as oral submucous fibrosis (OSMF). The drug, surgical and combination therapies are some of the several OSMF treatment options. The importance of colchicine in the treatment of oral submucous fibrosis is still unclear. Therefore, it is of interest to review the efficacy of colchicine in oral submucous fibrosis in terms of improving symptoms such as burning sensation and mouth opening. Known data shows colchicine is in alleviating these symptoms in OSMF patients.
- Open Access
- 16 January 2025
- Published by Sciencedomain International
- Vol. 8 (1) , 21-27
Oral Manifestation of Von Recklinghausen’s Disease: A Case Reports of Two Cases
Background: Von Recklinghausen’s disease also termed as “Neurofibromatosis type 1 (NF1)” is an autosomal dominant inherited disorder, characterized by various abnormalities such as neurofibroma, mainly in the skin and nerves. The classic manifestations include neurofibroma, café-au-lait macules, Iris Lisch nodules, optic glioma, axillary or inguinal freckling, and osseous dysplasia, neurological or cognitive impairment, scoliosis and oral and maxillofacial abnormalities. Various oral manifestations include soft tissues neurofibroma, dental abnormalities and osseous abnormalities. Case Presentation: We are reporting two cases of von Recklinghausen’s disease with predominant osseous abnormalities in one case while soft tissue neurofibroma on another case. Conclusion: Oral manifestations are not uncommon with NF1, including soft tissue, dental and osseous abnormalities. Oral specialist must be aware regarding the osseous and dental manifestation so that special attention and care must be provided to avoid further loss of dentition.
- 16 January 2025
- Published by Sciencedomain International
- Vol. 8 (1) , 21-27
Open AccessOral Manifestation of Von Recklinghausen’s Disease: A Case Reports of Two Cases
Background: Von Recklinghausen’s disease also termed as “Neurofibromatosis type 1 (NF1)” is an autosomal dominant inherited disorder, characterized by various abnormalities such as neurofibroma, mainly in the skin and nerves. The classic manifestations include neurofibroma, café-au-lait macules, Iris Lisch nodules, optic glioma, axillary or inguinal freckling, and osseous dysplasia, neurological or cognitive impairment, scoliosis and oral and maxillofacial abnormalities. Various oral manifestations include soft tissues neurofibroma, dental abnormalities and osseous abnormalities. Case Presentation: We are reporting two cases of von Recklinghausen’s disease with predominant osseous abnormalities in one case while soft tissue neurofibroma on another case. Conclusion: Oral manifestations are not uncommon with NF1, including soft tissue, dental and osseous abnormalities. Oral specialist must be aware regarding the osseous and dental manifestation so that special attention and care must be provided to avoid further loss of dentition.
- 7 January 2025
- Published by Sciencedomain International
- Vol. 8 (1) , 9-15
A Slow Flow Oral Vascular Malformation Managed by Sclerotherapy (3% Sodium Tetradecyl Sulfate) and Diode Laser (980nm): A Case Report
Vascular anomalies or lesions consist of wide spectrum of congenital lesions of vascular origin. Broadly, it is classified into proliferative vascular tumors and nonproliferative vascular malformations. Based on the hemodynamic flow, vascular malformations can be classified as high (arteriovenous malformation and arteriovenous fistulas) and low-flow lesions (capillary, venous, lymphatic). Venous malformations commonly seen in the oral region affecting lips, tongue, buccal mucosa, and palate, appear as bluish to deep purple, soft, compressible, pulsatile lesion. Various treatment modalities such as sclerotherapy, surgical resection, laser therapy, cryotherapy, medical therapy can be utilized to manage low-flow vascular malformations. Sclerotherapy and laser are both effective in the management of vascular malformation. We are reporting a case of low-flow vascular malformation managed by sclerotherapy with 3% sodium tetradecyl sulphate followed by diode laser 980nm. No case has been published in which sclerotherapy and laser has been utilized in the same lesion, making this case unique.
- 7 January 2025
- Published by Sciencedomain International
- Vol. 8 (1) , 9-15
A Slow Flow Oral Vascular Malformation Managed by Sclerotherapy (3% Sodium Tetradecyl Sulfate) and Diode Laser (980nm): A Case Report
Vascular anomalies or lesions consist of wide spectrum of congenital lesions of vascular origin. Broadly, it is classified into proliferative vascular tumors and nonproliferative vascular malformations. Based on the hemodynamic flow, vascular malformations can be classified as high (arteriovenous malformation and arteriovenous fistulas) and low-flow lesions (capillary, venous, lymphatic). Venous malformations commonly seen in the oral region affecting lips, tongue, buccal mucosa, and palate, appear as bluish to deep purple, soft, compressible, pulsatile lesion. Various treatment modalities such as sclerotherapy, surgical resection, laser therapy, cryotherapy, medical therapy can be utilized to manage low-flow vascular malformations. Sclerotherapy and laser are both effective in the management of vascular malformation. We are reporting a case of low-flow vascular malformation managed by sclerotherapy with 3% sodium tetradecyl sulphate followed by diode laser 980nm. No case has been published in which sclerotherapy and laser has been utilized in the same lesion, making this case unique.
- Open Access
- 23 October 2023
- Published by Hindawi Limited in Case Reports in Dermatological Medicine
- Vol. 2023, 1-10
Drug-Induced Erythema Multiforme
Erythema multiforme (EM) is an acute inflammatory, mucocutaneous, psychosomatic, and vesiculobullous condition that varies from minor to major forms. The acral distribution of target lesions is a characteristic of this condition. The aetiology of erythema multiforme is multifactorial. 90 of the cases are triggered by a herpes infection, whereas 10 occur secondary to drug intake. The offending drugs include nonsteroidal anti-inflammatory drugs, antibiotics, and anticonvulsants. The present case series discusses four cases of drug-induced erythema multiforme and their management.
- 23 October 2023
- Published by Hindawi Limited in Case Reports in Dermatological Medicine
- Vol. 2023, 1-10
Open AccessDrug-Induced Erythema Multiforme
Erythema multiforme (EM) is an acute inflammatory, mucocutaneous, psychosomatic, and vesiculobullous condition that varies from minor to major forms. The acral distribution of target lesions is a characteristic of this condition. The aetiology of erythema multiforme is multifactorial. 90 of the cases are triggered by a herpes infection, whereas 10 occur secondary to drug intake. The offending drugs include nonsteroidal anti-inflammatory drugs, antibiotics, and anticonvulsants. The present case series discusses four cases of drug-induced erythema multiforme and their management.
- Open Access
- 1 January 2023
- Published by Wiley in BioMed Research International
- Vol. 2023 (1) , 9375084
Prevalence and Distribution of Oral Mucosal Lesions and Normal Variants among Nepalese Population
Background. Oral mucosa is encountered by various lesions and normal variants. Some are not to be worried about, whereas others may be of significance. Knowing the prevalence of oral mucosal lesions in a particular region helps better evaluate, diagnose, and, thus, manage these lesions. Objectives. To assess the prevalence and distribution of oral mucosal lesions and normal variants among various age groups, genders, and sites of the orofacial region. Methods. This cross‐sectional study was conducted in the Department of Oral Medicine and Radiology, KIST Medical College and Teaching Hospital from January 2021 to March 2021. Three different proformas were designed according to age, gender, and location of lesions for entry as per the WHO’s guide. The obtained data were entered into a Microsoft Excel sheet for frequency analysis by SPSS, and the results were tabulated. Results. Among the records of 16572 (9703 (58.55%) males and 6869 (41.44%) females) OPD patients, 3495 (21.08%) (1934 (55.33%) males and 1561 (44.66%) females) had OMLs and 2314 (13.96%) (1626 (70.26%) males and 688 (29.73%) females) had normal mucosal variants. The most commonly seen OML categories were tobacco‐associated lesions, i.e., 2056 (34.07%), tongue lesions, i.e., 1598 (26.48%), oral potentially malignant disorders, i.e., 815 (13.50%), ulcers i.e., 728 (12.06%), and infectious lesions, i.e., 256 (4.24%). Conclusion. The Nepalese population has a wide range of oral mucosal lesions and normal variants, and this study has attempted to have baseline data for the same. The most common OML was smoker’s melanosis.
- 1 January 2023
- Published by Wiley in BioMed Research International
- Vol. 2023 (1) , 9375084
Open AccessPrevalence and Distribution of Oral Mucosal Lesions and Normal Variants among Nepalese Population
Background. Oral mucosa is encountered by various lesions and normal variants. Some are not to be worried about, whereas others may be of significance. Knowing the prevalence of oral mucosal lesions in a particular region helps better evaluate, diagnose, and, thus, manage these lesions. Objectives. To assess the prevalence and distribution of oral mucosal lesions and normal variants among various age groups, genders, and sites of the orofacial region. Methods. This cross‐sectional study was conducted in the Department of Oral Medicine and Radiology, KIST Medical College and Teaching Hospital from January 2021 to March 2021. Three different proformas were designed according to age, gender, and location of lesions for entry as per the WHO’s guide. The obtained data were entered into a Microsoft Excel sheet for frequency analysis by SPSS, and the results were tabulated. Results. Among the records of 16572 (9703 (58.55%) males and 6869 (41.44%) females) OPD patients, 3495 (21.08%) (1934 (55.33%) males and 1561 (44.66%) females) had OMLs and 2314 (13.96%) (1626 (70.26%) males and 688 (29.73%) females) had normal mucosal variants. The most commonly seen OML categories were tobacco‐associated lesions, i.e., 2056 (34.07%), tongue lesions, i.e., 1598 (26.48%), oral potentially malignant disorders, i.e., 815 (13.50%), ulcers i.e., 728 (12.06%), and infectious lesions, i.e., 256 (4.24%). Conclusion. The Nepalese population has a wide range of oral mucosal lesions and normal variants, and this study has attempted to have baseline data for the same. The most common OML was smoker’s melanosis.
- Open Access
- 26 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12) , e32959
Temporomandibular Joint Disorders Associated With Psoriatic Arthritis: A Report of Three Cases
Psoriatic arthritis is chronic inflammatory arthritis (seronegative) associated with psoriasis. Patients may present with different clinical symptoms as it progresses and involves multiple joints one after the other in an erratic pattern of aggravation and remission. A thorough examination is necessary for an accurate diagnosis and appropriate therapy of the disorder since it exhibits similar characteristics as reactive arthritis, rheumatoid arthritis, and ankylosing spondylitis. There haven't been many instances of the temporomandibular joint being involved, but records have to be maintained properly to assess its role in psoriatic arthritis. Here, we present three cases of temporomandibular joint disorders associated with psoriatic arthritis.
- 26 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12) , e32959
Open AccessTemporomandibular Joint Disorders Associated With Psoriatic Arthritis: A Report of Three Cases
Psoriatic arthritis is chronic inflammatory arthritis (seronegative) associated with psoriasis. Patients may present with different clinical symptoms as it progresses and involves multiple joints one after the other in an erratic pattern of aggravation and remission. A thorough examination is necessary for an accurate diagnosis and appropriate therapy of the disorder since it exhibits similar characteristics as reactive arthritis, rheumatoid arthritis, and ankylosing spondylitis. There haven't been many instances of the temporomandibular joint being involved, but records have to be maintained properly to assess its role in psoriatic arthritis. Here, we present three cases of temporomandibular joint disorders associated with psoriatic arthritis.
- Open Access
- 14 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12) , e32577
Lymphangioma of the Oral and Maxillofacial Region: A Report of Three Cases
Lymphangiomas, or lymphatic malformations (LM), are benign malformations of the lymphatic system characterized by abnormal proliferation of lymphatic vessels. It was first described by Virchow in 1854. They occur rarely in the oral cavity and involve the tongue dorsum more often. Though complete surgical excision is the gold standard and most desirable management, certain limitations restrict this approach. Laser therapy, cryotherapy, electrocautery, sclerotherapy, and intralesional injections of steroids and Bevacizumab are other treatment options in such cases. Here, we present three cases of diverse forms of lymphatic malformations treated with two different modalities of treatment.
- 14 December 2022
- Published by Springer Nature in Cureus
- Vol. 14 (12) , e32577
Open AccessLymphangioma of the Oral and Maxillofacial Region: A Report of Three Cases
Lymphangiomas, or lymphatic malformations (LM), are benign malformations of the lymphatic system characterized by abnormal proliferation of lymphatic vessels. It was first described by Virchow in 1854. They occur rarely in the oral cavity and involve the tongue dorsum more often. Though complete surgical excision is the gold standard and most desirable management, certain limitations restrict this approach. Laser therapy, cryotherapy, electrocautery, sclerotherapy, and intralesional injections of steroids and Bevacizumab are other treatment options in such cases. Here, we present three cases of diverse forms of lymphatic malformations treated with two different modalities of treatment.
- Open Access
- 17 September 2022
- Published by Wiley in International Journal of Dentistry
- Vol. 2022 (1) , 8269221
Comparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy for the Treatment of Oral Pyogenic Granuloma
Background. Pyogenic granuloma (PG) is a tumor‐like, non‐neoplastic lesion of the soft tissue that commonly appears in the oral cavity. Various treatment modalities have been discussed, including surgical excision, cryosurgery, curettage, electrodessication, corticosteroid injection, sclerotherapy, and lasers. This observational retrospective study compared effectiveness between diode lasers and sclerotherapy for PG treatment. Materials and Methods. From July 2016 to January 2021, data of oral PG cases treated with sclerotherapy and diode lasers were gathered. Patients were evaluated and categorized according to their gender, sex, site of lesions, size of lesions, number of sessions, details of side effects, details of the VAS (Visual Analogue Scale) on third postoperative day, response of treatment to individual groups, time required for complete resolution, and details of recurrence. Inferential statistical analysis was performed. Results. We included 73 patients, of whom 43 and 30 received laser and sclerotherapy treatment, respectively. Compared with the sclerotherapy group, the laser group had less side effects including pain, edema, ulceration, ecchymosis, infections, and scarring. The difference in postoperative pain (VAS scale) between the groups was statistically significant (p‐value 0.004). Complete remission was seen in the laser group, while 3 cases of the sclerotherapy group had no response (p‐value −0.034). The laser group experienced greater recurrence than did the sclerotherapy group. Conclusions. Both sclerotherapy with laser and 3% sodium tetradecyl sulfate are effective for treating oral PG. Sclerotherapy is more effective in preventing recurrence. In terms of side effects, diode lasers are superior to sclerotherapy.
- 17 September 2022
- Published by Wiley in International Journal of Dentistry
- Vol. 2022 (1) , 8269221
Open AccessComparative Evaluation of Efficacy and Safety of the Diode Laser (980 nm) and Sclerotherapy for the Treatment of Oral Pyogenic Granuloma
Background. Pyogenic granuloma (PG) is a tumor‐like, non‐neoplastic lesion of the soft tissue that commonly appears in the oral cavity. Various treatment modalities have been discussed, including surgical excision, cryosurgery, curettage, electrodessication, corticosteroid injection, sclerotherapy, and lasers. This observational retrospective study compared effectiveness between diode lasers and sclerotherapy for PG treatment. Materials and Methods. From July 2016 to January 2021, data of oral PG cases treated with sclerotherapy and diode lasers were gathered. Patients were evaluated and categorized according to their gender, sex, site of lesions, size of lesions, number of sessions, details of side effects, details of the VAS (Visual Analogue Scale) on third postoperative day, response of treatment to individual groups, time required for complete resolution, and details of recurrence. Inferential statistical analysis was performed. Results. We included 73 patients, of whom 43 and 30 received laser and sclerotherapy treatment, respectively. Compared with the sclerotherapy group, the laser group had less side effects including pain, edema, ulceration, ecchymosis, infections, and scarring. The difference in postoperative pain (VAS scale) between the groups was statistically significant (p‐value 0.004). Complete remission was seen in the laser group, while 3 cases of the sclerotherapy group had no response (p‐value −0.034). The laser group experienced greater recurrence than did the sclerotherapy group. Conclusions. Both sclerotherapy with laser and 3% sodium tetradecyl sulfate are effective for treating oral PG. Sclerotherapy is more effective in preventing recurrence. In terms of side effects, diode lasers are superior to sclerotherapy.